{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T11:11:33Z","timestamp":1698318693692},"reference-count":36,"publisher":"Akademiai Kiado Zrt.","issue":"22","license":[{"start":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T00:00:00Z","timestamp":1653782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2022,5,29]]},"abstract":"<jats:p><jats:italic>Bevezet\u00e9s \u00e9s c\u00e9lkit\u0171z\u00e9s:<\/jats:italic> Az Eur\u00f3pai Uni\u00f3ban a hepatitis\n                    C-v\u00edrussal (HCV) fert\u0151z\u00f6tt betegek k\u00e9tharmada nem tud a fert\u0151z\u00f6tts\u00e9g\u00e9r\u0151l. A WHO\n                    c\u00e9lja 2030-ra az \u00faj kr\u00f3nikus hepatitises esetek sz\u00e1m\u00e1nak 90%-os cs\u00f6kkent\u00e9se. A\n                    b\u00f6rt\u00f6n\u00f6kben a HCV-fert\u0151z\u00f6ttek ar\u00e1nya a lakoss\u00e1g\u00e9nak a t\u00edzszeres\u00e9t is el\u00e9rheti. A\n                    cikk a magyar b\u00fcntet\u00e9s-v\u00e9grehajt\u00e1si int\u00e9zetekben 2007 \u00e9s 2017 k\u00f6z\u00f6tt zajlott\n                    HCV-sz\u0171r\u0151 vizsg\u00e1lat eredm\u00e9nyeinek \u00f6sszefoglal\u00e1sa. <jats:italic>M\u00f3dszer:<\/jats:italic> Az\n                    \u00f6nk\u00e9ntes alap\u00fa anti-HCV-sz\u0171r\u0151 vizsg\u00e1latot k\u00f6vet\u0151en a pozit\u00edv esetekn\u00e9l HCV-PCR-\n                    \u00e9s -genot\u00edpus-meghat\u00e1roz\u00e1s t\u00f6rt\u00e9nt. A betegek \u00edr\u00e1sos beleegyez\u00e9se ut\u00e1n kezd\u0151d\u00f6tt\n                    el az interferonalap\u00fa kezel\u00e9s, mely a hepatol\u00f3gusok ir\u00e1ny\u00edt\u00e1s\u00e1val \u00e9s a\n                    b\u00fcntet\u00e9s-v\u00e9grehajt\u00e1si int\u00e9zetek eg\u00e9szs\u00e9g\u00fcgyi szem\u00e9lyzet\u00e9nek egy\u00fcttm\u0171k\u00f6d\u00e9s\u00e9vel\n                    t\u00f6rt\u00e9nt. <jats:italic>Eredm\u00e9nyek:<\/jats:italic> A magyar b\u00f6rt\u00f6n\u00f6k 84%-\u00e1ban folyik\n                    HCV-sz\u0171r\u0151 program \u00e9s -kezel\u00e9s. \u00d6sszesen 25\u00a0384 betegn\u00e9l t\u00f6rt\u00e9nt meg ezen id\u0151szak\n                    alatt az anti-HCV-sz\u0171r\u0151 vizsg\u00e1lat. A betegek 6,6%-\u00e1ban anti-HCV-pozitivit\u00e1st \u00e9s\n                    3,8%-\u00e1ban HCV-PCR-pozitivit\u00e1st tal\u00e1ltunk. A HCV-PCR-pozit\u00edv betegek 55,2%-\u00e1ban\n                    kezd\u0151d\u00f6tt el a kezel\u00e9s. Teljes id\u0151tartam\u00fa volt a kezel\u00e9s 143 betegn\u00e9l, id\u0151 el\u0151tt\n                    fejez\u0151d\u00f6tt be 162 betegn\u00e9l (42,6%), m\u00edg 75 betegn\u00e9l nem ismert a kezel\u00e9s\n                    id\u0151tartama. A rendelkez\u00e9sre \u00e1ll\u00f3, a kezel\u00e9s v\u00e9ge ut\u00e1ni 24. heti eredm\u00e9ny alapj\u00e1n\n                    a tart\u00f3s ter\u00e1pi\u00e1s v\u00e1lasz 88% volt. <jats:italic>Megbesz\u00e9l\u00e9s:<\/jats:italic> A\n                    b\u00fcntet\u00e9s-v\u00e9grehajt\u00e1si int\u00e9zetekben foly\u00f3 HCV-sz\u0171r\u0151 \u00e9s -kezel\u00e9si program egy j\u00f3l\n                    m\u0171k\u00f6d\u0151 rendszer. A sikeres kezel\u00e9sben nagy szerepe van a betegek\n                    felvil\u00e1gos\u00edt\u00e1s\u00e1nak, a hepatol\u00f3gus koll\u00e9g\u00e1k \u00e9s a b\u00f6rt\u00f6n\u00f6k eg\u00e9szs\u00e9g\u00fcgyi dolgoz\u00f3i\n                    k\u00f6z\u00f6tti egy\u00fcttm\u0171k\u00f6d\u00e9snek. <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic> Eredm\u00e9nyeink azt\n                    mutatj\u00e1k, hogy a \u201etest and treat\u201d gyakorlat a HCV mikroelimin\u00e1ci\u00f3j\u00e1nak\n                    kivitelezhet\u0151 m\u00f3dja a b\u00f6rt\u00f6n\u00f6kben. Orv Hetil. 2022; 163(22): 871\u2013878.<\/jats:p>","DOI":"10.1556\/650.2022.32492","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T07:26:54Z","timestamp":1666769214000},"page":"871-878","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":1,"title":["A hepatitis C-v\u00edrus sz\u0171r\u00e9s\u00e9nek \u00e9s kezel\u00e9s\u00e9nek 10 \u00e9ves tapasztalata a b\u00f6rt\u00f6n\u00f6kben"],"prefix":"10.1556","volume":"163","author":[{"given":"Kl\u00e1ra","family":"Werling","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Seb\u00e9szeti, Transzplant\u00e1ci\u00f3s \u00e9s Gasztroenterol\u00f3giai Klinika Budapest, \u00dcll\u0151i \u00fat 78., 1082 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mih\u00e1ly","family":"Makara","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Szent L\u00e1szl\u00f3 Telephely Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Nemesi","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Szent L\u00e1szl\u00f3 Telephely Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Budai Hepatol\u00f3giai Centrum Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"Schneider","sequence":"additional","affiliation":[{"name":"Markusovszky Egyetemi Oktat\u00f3k\u00f3rh\u00e1z, Infektol\u00f3giai Oszt\u00e1ly Szombathely Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildik\u00f3","family":"Bali","sequence":"additional","affiliation":[{"name":"Tolna Megyei Balassa J\u00e1nos K\u00f3rh\u00e1z, Fert\u0151z\u0151 Oszt\u00e1ly Szeksz\u00e1rd Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Enyedi","sequence":"additional","affiliation":[{"name":"Markhot Ferenc Oktat\u00f3k\u00f3rh\u00e1z \u00e9s Rendel\u0151int\u00e9zet, Infektol\u00f3giai Oszt\u00e1ly Eger Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Jancsik","sequence":"additional","affiliation":[{"name":"Ken\u00e9zy Gyula K\u00f3rh\u00e1z-Rendel\u0151int\u00e9zet, Debreceni Egyetem, Kihelyezett Infektol\u00f3giai Tansz\u00e9k Debrecen Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"K\u00e1fony","sequence":"additional","affiliation":[{"name":"Szent Borb\u00e1la K\u00f3rh\u00e1z, Gasztroenterol\u00f3giai Oszt\u00e1ly Tatab\u00e1nya Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikl\u00f3s","family":"Lesch","sequence":"additional","affiliation":[{"name":"Szabolcs-Szatm\u00e1r-Bereg Megyei K\u00f3rh\u00e1zak \u00e9s Egyetemi Oktat\u00f3k\u00f3rh\u00e1z, J\u00f3sa Andr\u00e1s Oktat\u00f3k\u00f3rh\u00e1z, Infektol\u00f3giai Oszt\u00e1ly Ny\u00edregyh\u00e1za Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Lombay","sequence":"additional","affiliation":[{"name":"Borsod-Aba\u00faj-Zempl\u00e9n Megyei K\u00f6zponti K\u00f3rh\u00e1z \u00e9s Egyetemi Oktat\u00f3k\u00f3rh\u00e1z, II. Belgy\u00f3gy\u00e1szati Oszt\u00e1ly Miskolc Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Fej\u00e9r Megyei Szent Gy\u00f6rgy Egyetemi Oktat\u00f3 K\u00f3rh\u00e1z, Infektol\u00f3giai Oszt\u00e1ly Sz\u00e9kesfeh\u00e9rv\u00e1r Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"Ozsv\u00e1r","sequence":"additional","affiliation":[{"name":"Fej\u00e9r Megyei Szent Gy\u00f6rgy Egyetemi Oktat\u00f3 K\u00f3rh\u00e1z, Infektol\u00f3giai Oszt\u00e1ly Sz\u00e9kesfeh\u00e9rv\u00e1r Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1rp\u00e1d","family":"Patai","sequence":"additional","affiliation":[{"name":"Markusovszky Egyetemi Oktat\u00f3k\u00f3rh\u00e1z, Infektol\u00f3giai Oszt\u00e1ly Szombathely Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"P\u00e9terfi","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Klinikai K\u00f6zpont, I. Belgy\u00f3gy\u00e1szati Klinika P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Pusztay","sequence":"additional","affiliation":[{"name":"\u00c9szak-K\u00f6z\u00e9p-budai Centrum, \u00daj Szent J\u00e1nos K\u00f3rh\u00e1z \u00e9s Szakrendel\u0151, I. Belgy\u00f3gy\u00e1szati Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"Ny\u00edr\u0151 Gyula Orsz\u00e1gos Pszichi\u00e1triai \u00e9s Addiktol\u00f3giai Int\u00e9zet, Hepatol\u00f3giai Szakambulancia Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Szl\u00e1vik","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Szent L\u00e1szl\u00f3 Telephely Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, Belgy\u00f3gy\u00e1szati \u00e9s Onkol\u00f3giai Klinika Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rta","family":"Varga","sequence":"additional","affiliation":[{"name":"B\u00e9k\u00e9s Megyei K\u00f6zponti K\u00f3rh\u00e1z, R\u00e9thy P\u00e1l Tagk\u00f3rh\u00e1z, Gasztroenterol\u00f3giai Oszt\u00e1ly B\u00e9k\u00e9scsaba Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"G\u00e1cs","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Szent L\u00e1szl\u00f3 Telephely Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"\u00dajhelyi","sequence":"additional","affiliation":[{"name":"Mikromikomed Kft. Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nemes Nagy","sequence":"additional","affiliation":[{"name":"B\u00fcntet\u00e9s-v\u00e9grehajt\u00e1s Orsz\u00e1gos Parancsnoks\u00e1ga, Eg\u00e9szs\u00e9g\u00fcgyi F\u0151oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"1 Thrift","year":"2017","unstructured":"1 Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017; 14: 122-132.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2 Papatheodoridis GV, Hatzakis A, Cholongitas E, et al, Hepatitis C: the beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe. J Viral Hepat. 2018; 25(Suppl 1): 6-17.","DOI":"10.1111\/jvh.12875"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12879-018-3242-2","article-title":"Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015","volume":"18","author":"3 Kivimets","year":"2018","unstructured":"3 Kivimets K, Uusk\u00fcla A, Lazarus JV, et al. Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015. BMC Infect Dis. 2018; 18: 339-346.","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/jech.2006.051599","article-title":"Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis","volume":"62","author":"4 Vescio","year":"2008","unstructured":"4 Vescio MF, Longo B, Babudieri S, et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health 2008; 62: 305-313.","journal-title":"J Epidemiol Community Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1800614","DOI":"10.2807\/1560-7917.ES.2019.24.30.1800614","article-title":"Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU\/EEA: a systematic review","volume":"24","author":"5 Mason","year":"2019","unstructured":"5 Mason LM, Duffell E, Veldhuijzen IK, et al. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU\/EEA: a systematic review. Euro Surveill. 2019; 24: 1800614.","journal-title":"Euro Surveill"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6 Hunyady B, Gerlei Z, Gervain J, et al. Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017. [A hepatitis C-v\u00edrus-fert\u0151z\u00e9s sz\u0171r\u00e9se, diagnosztik\u00e1ja, antivir\u00e1lis ter\u00e1pi\u00e1ja, kezel\u00e9s ut\u00e1ni gondoz\u00e1sa. Magyar konszenzusaj\u00e1nl\u00e1s. \u00c9rv\u00e9nyes: 2017. szeptember 22-t\u0151l.] Orv Hetil. 2018; 159(Suppl 1): 3-23. [Hungarian]","DOI":"10.1556\/650.2018.31003"},{"key":"ref6","unstructured":"7 Chen DS, Hamoudi W, Mustapha B, et al. Strategies to manage hepatitis C virus infection disease burden - Volume 4. J Viral Hepat. 2017; 24(Suppl 2): 44-63."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8 European Association for the Study of the Liver (EASL). Recommendations on treatment of hepatitis C 2015. J Hepatol. 2015; 63: 199-236.","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9 Gountas I, Sypsa V, Blach S, et al. HCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era. PLoS ONE 2018; 13: e0202109.","DOI":"10.1371\/journal.pone.0202109"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/003335491412900213","article-title":"Hepatitis C seroprevalence among prison inmates since 2001: still high but declining","volume":"129","author":"10 Varan","year":"2014","unstructured":"10 Varan AK, Mercer DW, Stein MS, et al. Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. Public Health Rep. 2014; 129: 187-195.","journal-title":"Public Health Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"11 Dolan","year":"2016","unstructured":"11 Dolan K, Wirtz AL, Moazen B, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet 2016; 388: 1089-1102.","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12954-018-0246-6","article-title":"A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons","volume":"15","author":"12 Lafferty","year":"2018","unstructured":"12 Lafferty L, Wild TC, Rance J, et al. A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons. Harm Reduct J. 2018; 15: 39.","journal-title":"Harm Reduct J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis","volume":"58","author":"13 Larney","year":"2013","unstructured":"13 Larney S, Kopinski H, Beckwith CG, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology 2013; 58: 1215-1224.","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/epirev\/mxy003","article-title":"HIV and viral hepatitis among imprisoned key populations","volume":"40","author":"14 Wirtz","year":"2018","unstructured":"14 Wirtz AL, Yeh PT, Flath NL, et al. HIV and viral hepatitis among imprisoned key populations. Epidemiol Rev. 2018; 40: 12-26.","journal-title":"Epidemiol Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/epirev\/mxy001","article-title":"Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the European Union\/European economic area","volume":"40","author":"15 Tavoschi","year":"2018","unstructured":"15 Tavoschi L, Vroling H, Madeddu G, et al. Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the European Union\/European economic area. Epidemiol Rev. 2018; 40: 105-120.","journal-title":"Epidemiol Rev"},{"key":"ref15","unstructured":"16 European Centre for Disease Prevention and Control (ECDC)\/European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Public health guidance on active case finding of communicable diseases in prison settings. EDCD and EMCDDA, Stockholm and Lisbon, 2018. Available from: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/Active-case-finding-communicable-diseases-in-prison.pdf [accessed: January 20, 2022]."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17 He T, Li K, Roberts MS, et al. Prevention of hepatitis C by screening and treatment in U.S. prisons. Ann Intern Med. 2016; 164: 84-92.","DOI":"10.7326\/M15-0617"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","article-title":"Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment","volume":"7","author":"18 Zampino","year":"2015","unstructured":"18 Zampino R, Coppola N, Sagnelli C, et al. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015; 7: 2323-2330.","journal-title":"World J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12954-018-0231-0","article-title":"Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis","volume":"15","author":"19 Behzadifar","year":"2018","unstructured":"19 Behzadifar M, Gorji HA, Rezapour A, et al. Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis. Harm Reduct J. 2018; 15: 24.","journal-title":"Harm Reduct J"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20 Makara M, Horv\u00e1th G, Szalay F, et al. Organizational characteristics of treatment for chronic hepatitis in Hungary: Hepatitis Registry and Priority Index. [A kr\u00f3nikus v\u00edrushepatitisek hazai ell\u00e1t\u00e1si rendszer\u00e9nek saj\u00e1toss\u00e1gai: Hepatitis Regiszter \u00e9s Priorit\u00e1si Index.] Orv Hetil. 2013; 154: 1151-1155. [Hungarian]","DOI":"10.1556\/OH.2013.29671"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21 Makara M, Horv\u00e1th G, Gervain J, et al. Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis. [Aj\u00e1nl\u00e1s a B-, a C- \u00e9s a D-v\u00edrus hepatitisek diagnosztik\u00e1j\u00e1ra \u00e9s antivir\u00e1lis kezel\u00e9s\u00e9re.] Orv Hetil. 2012; 153: 375-394. [Hungarian]","DOI":"10.1556\/OH.2012.29338"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22 Hunyady B, Gerlei Z, Gervain J, et al. Diagnosis, treatment, and follow-up of hepatitis C virus related liver disease. Hungarian national consensus guideline. [Hepatitis C-v\u00edrus-fert\u0151z\u00e9s: diagnosztika, antivir\u00e1lis ter\u00e1pia, kezel\u00e9s ut\u00e1ni gondoz\u00e1s. Magyar konszenzusaj\u00e1nl\u00e1s.] Orv Hetil. 2015; 156(Suppl 1): 3-23. [Hungarian]","DOI":"10.1556\/OH.2015.30345"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23 Hunyady B, Gerlei Z, Gervain J, et al. Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 15 October 2016. [A hepatitis C-v\u00edrus-fert\u0151z\u00e9s sz\u0171r\u00e9se, diagnosztik\u00e1ja, antivir\u00e1lis ter\u00e1pi\u00e1ja, kezel\u00e9s ut\u00e1ni gondoz\u00e1sa. Magyar konszenzusaj\u00e1nl\u00e1s. \u00c9rv\u00e9nyes: 2016. okt\u00f3ber 15-t\u0151l.] Orv Hetil. 2017; 158(Suppl 1): 3-22. [Hungarian]","DOI":"10.1556\/650.2017.30688"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 Gervain J. Analysis of hepatitis C virus type and subtype distribution in Hungary. [Magyarorsz\u00e1gi C-v\u00edrus-hepatitises betegek v\u00edrust\u00edpus \u00e9s szubt\u00edpusmegoszl\u00e1s\u00e1nak elemz\u00e9se.] Orv Hetil. 2018;159(Suppl 2): 2-8. [Hungarian]","DOI":"10.1556\/650.2018.31177"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-018-0230-1","article-title":"Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries","volume":"15","author":"25 Bielen","year":"2018","unstructured":"25 Bielen R, Stumo SR, Halford R, et al. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct J. 2018; 15: 25.","journal-title":"Harm Reduct J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugpo.2018.04.003","article-title":"Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: a systematic review","volume":"57","author":"26 Kronfli","year":"2018","unstructured":"26 Kronfli N, Linthwaite B, Kouyoumdjian F, et al. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: a systematic review. Int J Drug Policy 2018; 57: 95-103.","journal-title":"Int J Drug Policy"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27 Chew KW, Allen SA, Taylor LE, et al. Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C. J Clin Gastroenterol. 2009; 43: 686-691. [Erratum: J Clin Gastroenterol. 2009; 43: 1010.]","DOI":"10.1097\/MCG.0b013e31818dd94c"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28 Iacomi F, Iannicelli G, Franceschini A, et al. HCV infected prisoners: should they be still considered a difficult to treat population? BMC Infect Dis. 2013; 13: 374.","DOI":"10.1186\/1471-2334-13-374"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jvh.12580","article-title":"A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy","volume":"23","author":"29 Aspinall","year":"2016","unstructured":"29 Aspinall EJ, Mitchell W, Schofield J, et al. A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy. J Viral Hepat. 2016; 23: 1009-1016.","journal-title":"J Viral Hepat"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40352-017-0055-0","article-title":"The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care","volume":"5","author":"30 Hochstatter","year":"2017","unstructured":"30 Hochstatter KR, Stockman LJ, Holzmacher R, et al. The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care. Health Justice 2017; 5: 10.","journal-title":"Health Justice"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31 Redman JS, Sterling RK Treating HCV in a captive audience: eradication efforts in the prison microenvironment. Am J Gastroenterol. 2018; 113: 1585-1587.","DOI":"10.1038\/s41395-018-0201-x"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32 Negro F. Epidemiology of hepatitis C in Europe. Dig Liver Dis. 2014; 46(Suppl 5): S158-S64.","DOI":"10.1016\/j.dld.2014.09.023"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/add.13783","article-title":"Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland","volume":"112","author":"33 Stone","year":"2017","unstructured":"33 Stone J, Martin NK, Hickman M, et al. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Addiction 2017; 112: 1302-1314.","journal-title":"Addiction"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/cid\/cir991","article-title":"Transmission of hepatitis C virus infection through tattooing and piercing: a critical review","volume":"54","author":"Tohme RA","year":"2012","unstructured":"34 Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 2012; 54: 1167-1178.","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ajic.2006.08.002","article-title":"Tattooing in prisons - not such a pretty picture","volume":"35","author":"35 Hellard","year":"2007","unstructured":"35 Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons - not such a pretty picture. Am J Infect Control. 2007; 35: 477-480.","journal-title":"Am J Infect Control"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.annepidem.2018.02.002","article-title":"Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system","volume":"28","author":"36 Poulin","year":"2018","unstructured":"36 Poulin C, Courtemanche Y, Serhir B, et al. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system. Ann Epidemiol. 2018; 28: 231-235.","journal-title":"Ann Epidemiol"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/22\/article-p871.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/22\/article-p871.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/22\/article-p871.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T16:06:41Z","timestamp":1698250001000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/22\/article-p871.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,29]]},"references-count":36,"journal-issue":{"issue":"22"},"URL":"https:\/\/doi.org\/10.1556\/650.2022.32492","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,29]]}}}